Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Pyridam Farma Tbk's Total Liabilities for the quarter that ended in Mar. 2026 was Rp6,128,736 Mil.
PT Pyridam Farma Tbk's quarterly Total Liabilities
declined
from Sep. 2025 (Rp6,186,521.56 Mil) to Dec. 2025 (Rp5,785,948.93 Mil) but then
increased
from Dec. 2025 (Rp5,785,948.93 Mil) to Mar. 2026 (Rp6,128,735.62 Mil).
PT Pyridam Farma Tbk's annual Total Liabilities
increased
from Dec. 2023 (Rp1,170,209.73 Mil) to Dec. 2024 (Rp4,771,544.42 Mil) and
increased
from Dec. 2024 (Rp4,771,544.42 Mil) to Dec. 2025 (Rp5,785,948.93 Mil).
PT Pyridam Farma Tbk Total Liabilities Related Terms
PT Pyridam Farma Tbk Total Liabilities Historical Data
* Premium members only.
The historical data trend for PT Pyridam Farma Tbk's Total Liabilities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Pyridam Farma Tbk Total Liabilities Calculation
Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.
PT Pyridam Farma Tbk's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Total Liabilities of Rp6,128,736 Mil mean?
PT Pyridam Farma Tbk (ISX:PYFA) has a Total Liabilities of Rp6,128,736 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for PT Pyridam Farma Tbk and its competitors.
Is PT Pyridam Farma Tbk's Total Liabilities too high?
PT Pyridam Farma Tbk's current Total Liabilities is Rp6,128,736 Mil. Overall, PT Pyridam Farma Tbk has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PT Pyridam Farma Tbk's Total Liabilities compare to ZTS and UTHR?
PT Pyridam Farma Tbk's Total Liabilities of Rp6,128,736 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for PT Pyridam Farma Tbk and its competitors. PT Pyridam Farma Tbk's current Total Liabilities is Rp6,128,736 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Pyridam Farma Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Pyridam Farma Tbk (ISX:PYFA) is currently considered Fairly Valued. The stock's GF Value™ is Rp212.27, compared to a current price of Rp206.00 — trading 3% below its estimated fair value. The current Total Liabilities is Rp6,128,736 Mil. PT Pyridam Farma Tbk's overall GF Score™ is 66/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For PT Pyridam Farma Tbk (ISX:PYFA), the current Total Liabilities is Rp6,128,736 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Pyridam Farma Tbk (ISX:PYFA) Overvalued in 2026?
Based on GuruFocus' analysis, PT Pyridam Farma Tbk stock appears to be undervalued.
The current stock price of Rp206.00 is trading 3% below its estimated GF Value™ of Rp212.27.
GuruFocus considers PT Pyridam Farma Tbk to be Fairly Valued.
Key valuation signals for ISX:PYFA:
Total Liabilities: Rp6,128,736 Mil
GF Value™: Rp212.27 vs. price of Rp206.00 (3% below fair value)
No single metric tells the full story. See the ISX:PYFA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Pyridam Farma Tbk is engaged in the production and development of pharmaceutical medicines and the trading of medical equipment. It manufactures products namely Antibiotics, Vitamins, Supplements, and Traditional herbal care. It operates through two segments namely Pharmaceutical products, Esthetics, and Toll manufacturing services; and Medical equipment Products segment. The company derives maximum revenue from Pharmaceutical products, Esthetics, and Toll manufacturing services. The company's products include consumer health, Derma, prescription, and biomedilab.
66GF Score
Get the complete analysis for ISX:PYFA
Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:PYFA has been successfully added to your 
